glycine has been researched along with T-Cell Lymphoma in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In ixazomib-treated TCL and HL cells, transient inhibition followed by full recovery of proteasomal activity observed was accompanied by induction of proteasomal gene expression with NFE2L2 (also termed NRF2) as a prominent upstream regulator." | 5.56 | Combinatorial ixazomib and belinostat therapy induces NFE2L2-dependent apoptosis in Hodgkin and T-cell lymphoma. ( Beheshti, A; David, KA; Evens, AM; McDonald, JT; Passero, FC; Ravi, D, 2020) |
| "In ixazomib-treated TCL and HL cells, transient inhibition followed by full recovery of proteasomal activity observed was accompanied by induction of proteasomal gene expression with NFE2L2 (also termed NRF2) as a prominent upstream regulator." | 1.56 | Combinatorial ixazomib and belinostat therapy induces NFE2L2-dependent apoptosis in Hodgkin and T-cell lymphoma. ( Beheshti, A; David, KA; Evens, AM; McDonald, JT; Passero, FC; Ravi, D, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Passero, FC | 1 |
| Ravi, D | 2 |
| McDonald, JT | 1 |
| Beheshti, A | 2 |
| David, KA | 1 |
| Evens, AM | 2 |
| Zullo, KM | 1 |
| Guo, Y | 1 |
| Cooke, L | 1 |
| Jirau-Serrano, X | 1 |
| Mangone, M | 1 |
| Scotto, L | 1 |
| Amengual, JE | 1 |
| Mao, Y | 1 |
| Nandakumar, R | 1 |
| Cremers, S | 1 |
| Duong, J | 1 |
| Mahadevan, D | 1 |
| O'Connor, OA | 1 |
| Abermil, N | 1 |
| Passero, F | 1 |
| Sharma, J | 1 |
| Coyle, M | 1 |
| Kritharis, A | 1 |
| Kandela, I | 1 |
| Hlatky, L | 1 |
| Sitkovsky, MV | 1 |
| Mazar, A | 1 |
| Gartenhaus, RB | 1 |
3 other studies available for glycine and T-Cell Lymphoma
| Article | Year |
|---|---|
Combinatorial ixazomib and belinostat therapy induces NFE2L2-dependent apoptosis in Hodgkin and T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boron Compounds; Cell Line, Tumor; Down-R | 2020 |
Aurora A Kinase Inhibition Selectively Synergizes with Histone Deacetylase Inhibitor through Cytokinesis Failure in T-cell Lymphoma.
Topics: Aminopterin; Animals; Aurora Kinase A; Azepines; Boron Compounds; Cell Cycle; Cell Line, Tumor; Cent | 2015 |
Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Blotting, Western; Boron Compounds; Cell Proliferation; Check | 2016 |